Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcyt.2017.02.002 http://scihub22266oqcxt.onion/10.1016/j.jcyt.2017.02.002 C5410175!5410175!28233640     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cytotherapy 2017 ; 19 (4): 445-57 Nephropedia Template TP {{tp|p=28233640|t=2017. Mesenchymal Stem Cells for the Delivery of Oncolytic Viruses in Gliomas |pdf=|usr=}}{{28233640}} gab.com Text Mesenchymal Stem Cells for the Delivery of Oncolytic Viruses in Gliomas JO: Cytotherapy http://www.kidney.de/pget.php?&tw=1&pmid=28233640 #FOAvip Mesenchymal stem cells (MSCs) are a type of adult stem cell that have been exploited for the treatment of a variety of diseases, including cancer. In particular, MSCs have been studied extensively for their ability to treat glioblastoma (GBM), the most common and deadly form of brain cancer in adults. MSCs are attractive therapeutics because they can be obtained relatively easily from patients, are capable of being expanded in vitro, can be easily engineered, and because they inherently are capable of homing to tumors, making them ideal vehicles for delivering biological anti-tumoral agents. Oncolytic viruses are promising biological therapeutic agents that have been employed in the treatment of GBMs, and MSCs are currently being explored as means of delivering these viruses. Here we review the role of MSCs in the treatment of GBMs, focusing on the intersection of MSCs and oncolytic viruses. Twit Text FOAVip Mesenchymal Stem Cells for the Delivery of Oncolytic Viruses in Gliomas ????Cytotherapy http://www.kidney.de/pget.php?&tw=1&pmid=28233640 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28233640 #FOAvip English Wikipedia <ref>{{Cite pmid|28233640}}</ref> Mesenchymal Stem Cells for the Delivery of Oncolytic Viruses in Gliomas #MMPMID28233640 Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF Cytotherapy 2017[Apr]; 19 (4): 445-57 PMID28233640show ga Mesenchymal stem cells (MSCs) are a type of adult stem cell that have been exploited for the treatment of a variety of diseases, including cancer. In particular, MSCs have been studied extensively for their ability to treat glioblastoma (GBM), the most common and deadly form of brain cancer in adults. MSCs are attractive therapeutics because they can be obtained relatively easily from patients, are capable of being expanded in vitro, can be easily engineered, and because they inherently are capable of homing to tumors, making them ideal vehicles for delivering biological anti-tumoral agents. Oncolytic viruses are promising biological therapeutic agents that have been employed in the treatment of GBMs, and MSCs are currently being explored as means of delivering these viruses. Here we review the role of MSCs in the treatment of GBMs, focusing on the intersection of MSCs and oncolytic viruses. äMesenchymal Stem Cells for the Delivery of Oncolytic Viruses in Glioma(epmc).pdf DeepDyve Pubget Overpricing